Case | Age | Sex | Diagnosis | Preope Tx | NCCNa | UICCb | Procedure | rRHA resection | rRHA origin | rRHA-tumor |
---|
1 | 65 | M | PDAC | No | R | cIII | SSPPD |  +  | CA | Abutment |
2 | 65 | M | PDAC | GS | BR | ycIII | Exploratory laparotomy | − | SMA | Involvement |
3 | 75 | F | DBDC | No | – | cIIB | SSPPD |  +  | SMA | Abutment |
4 | 71 | M | PDAC | No | R | cIIA | SSPPD |  +  | SMA | Abutment |
5 | 67 | F | PDAC | S-1 + RT GnP | LA | ycIIB | SSPPD |  +  | SMA | Abutment |
- rRHA replaced right hepatic artery; PDAC pancreatic ductal adenocarcinoma; DBDC distal bile duct cancer; PreopeTx preoperative therapy; GS gemcitabine + S-1; RT radiation; GnP gemecitabine + nab-paclitaxel; R resectable; BR borderline resectable; LA locally advanced; SSPPD subtotal stomach-preserving pancreaticoduodenectomy; CA celiac artery; SMA superior mesenteric artery
- aNCCN: Resectability criteria from the NCCN Guideline version1.2021 Pancreatic Adenocarcinoma before surgery
- bUICC: The UICC TNM classification 7th edition